Secondary structures in the MS2 genome are likely to be important for RNA targeting, so the six spacers included in each CRISPR were designed to target locations with varying degrees of predicted secondary structure. These structures are similar to secondary structures predicted for the LasR mRNA, which is purported to be targeted for degradation by the type I-F CRISPR system in PA14 3 .
To measure the efficiency of phage defense, we performed a series of plaque assays ( Fig. 1c ). None of the CRISPRs designed to target MS2 provided protection. To confirm that our experimental system is functional, we replaced the MS2 targeting CRISPR, with a CRISPR designed to target lambda (λ) phage (CRISPR-λ). Cells that express Csy, Cas2/3, and a synthetic CRISPR designed to target λ-phage, resulted in a 5-log reduction of plaques, as compared to non-targeting controls (i.e., CRISPR-DMS3) ( Fig. 1c, d) .
Importantly, the work presented here was not designed to replicate the previously published work by Li et al., but rather our intention was to determine if the noncanonical crRNA-guided recognition rules described by these authors could be generally applied for programable defense against RNA phages. Unlike the type III CRISPR systems described by Silas et al. 7 , the type I-F systems do not contain a reverse transcriptase, which would be necessary to incorporate new spacers from RNA-based parasites. Here, we by-pass new spacer acquisition, by creating synthetic CRISPRs designed to target the MS2 genome. Regardless of the design rule (canonical or nonconical), none of the MS2 targeting CRISPRs were capable of knocking down RNA phage infection. This biological result is supported by recent structural, biochemical, and biological assays which all show that Cas2/3 nuclease recruitment requires a conformational change in the Csy complex that is dependent on displacement of a noncomplementary strand during crRNA-guided base pairing to the target DNA 4 . We acknowledge that CRISPR Every sixth nucleobase is covered by a beta-hairpin on Cas7 and these bases do not contribute to target interactions 4, 5 . Target binding drives a conformational change in the Csy complex that recruits the Cas2/3 nuclease for target cleavage. In contrast to dsDNA binding, the proposed RNA-binding model requires the recognition of a single-stranded "PAM-like" sequence followed by a 12-nt core sequence. 
